Clinical Trial

The Efficacy and Safety of Luspatercept in Improving Early Anemia After HSCT

Name: The Efficacy and Safety of Luspatercept in Improving Early Anemia After HSCT — clinical trial record (NCT07450313)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate whether luspatercept can improve the efficacy and safety of anemia treatment in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation.

Trial Details

NCT Number	NCT07450313
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	HSCT
Enrollment	20 participants
Start Date	2026-03-14
Primary Completion	2027-06-14 (estimated)
Study Completion	2027-06-14 (estimated)
Updated on ClinicalTrials.gov	2026-03-04